Neuralstem IncAdd to My Watchlist

CUR:USNASDAQ CMIndustry: Medical-Biomedical/Gene
  • 1.51
    Last
  • 0.03  2.03%
    Today's Change
  • 1.48
    Previous Close
  • Today
     
    1.25
    4.11
    52 Week Low - High
8:10 pm ET 8/28/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding92 million
Market Cap$139 million
Return on Equity ttm-106.10%
Last DividendCUR:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.227
EPS: Year Est. 12/15 ttm-0.270
 
EPS: Quarterly Actual 6/15 -0.06
EPS: Quarterly Est. 9/15 -0.07
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate3.70
Company Description
Neuralstem Inc. provides medical research services. The Company develops and commercializes clinical treatment for central nervous system diseases. Neuralstem serves the medical field worldwide.
Revenue$18,830
Net Income$-23 million
Total Assets$30 million
Employees25
Web Sitewww.neuralstem.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!